These findings corroborate our results, implicating MS4A4A as a risk factor in both IPF and lung cancer, potentially contributing to lung tissue damage and fibrosis through immune system dysregulation. The gene discussed is MS4A4A; the disease is idiopathic pulmonary fibrosis.